Hamada, Yuki
Matsuoka, Hideki
Sato, Takeo
Hamada, Kyosuke
Shimada, Takumi
Kawabata, Yutaro
Iwamoto, Kana
Ikeda, Mei
Takaguchi, Go
Higuchi, Yujiro
Takashima, Hiroshi
Article History
Received: 18 October 2025
Revised: 13 February 2026
Accepted: 28 February 2026
First Online: 13 March 2026
Compliance with ethical standards
:
: Yuki Hamada: reports lecture fees from Daiichi Sankyo Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Novartis Pharma Co. Ltd., Medtronic Co. Ltd., Medico’s Hirata Co. Ltd., Johnson & Johnson Co. Ltd., Merit Medical Systems Inc., and Kaneka Co. Ltd. outside the submitted work. Hideki Matsuoka: reports lecture fees from Daiichi Sankyo Co. Ltd., Pfizer Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Kowa Co. Ltd., UCB Japan Co. Ltd., Novartis Pharma Co. Ltd., and AstraZeneca Co. Ltd. outside the submitted work. Takeo Sato: reports lecture fees from Pfizer Japan Inc. and Kowa Co. Ltd. outside the submitted work. Kyosuke Hamada: reports lecture fees from Medtronic Co., Ltd., and Japan Lifeline Co., Ltd. outside the submitted work. Takumi Shimada: none Yutaro Kawabata: none Kana Iwamoto: none Mei Ikeda: none Go Takaguchi: none Yujiro Higuchi: none Hiroshi Takashima: reports lecture fees from Daiichi Sankyo Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Biogen Japan Ltd., Eisai Co. Ltd., FP Pharmaceutical Corp., Alnylam Pharmaceuticals Inc., Kyowa Kirin Co. Ltd., Alexion Pharmaceuticals Inc., Argenx Japan K.K., Cyberdyne Inc., Takeda Pharmaceutical Co. Ltd., CSL Behring K.K., Asahi Kasei Medical Co. Ltd., Chugai Pharmaceutical Co. Ltd., Sumitomo Pharma Co. Ltd., Amgen Inc., Japan Blood Products Organization, Cosmic Corporation Co. Ltd., and Ono Pharmaceutical Co. Ltd. outside the submitted work. Hiroshi Takashima also reports scholarship donations from Shin Nippon Biomedical Laboratories Ltd. and Asahi Kasei Medical Co. Ltd. outside the submitted work.